Cardinal Stefan Wyszyński Institute of Cardiology, Warsaw, Poland.
Kardiol Pol. 2010 May;68(5):512-8.
The assessment of defibrillation energy requirement (DER) is a standard practice during cardioverter-defibrillator (ICD) implantation. It is recommended to assure that the energy at least 10 J below the maximal energy deliverable by the implanted device successfully converts the induced ventricular fibrillation (VF). The cardiac resynchronisation therapy with defibrillator (CRT-D) recipients are at increased risk of developing serious complications due to repeated VF induction.
To define the prevalence of high DER among CRT-D recipients and to determine the factors which allow to obtain defibrillation safety margin.
We examined all patients who underwent CRT-D implantation between June 2006 and June 2009 in our institution. The verification of the DER required at least one termination of the induced VF with the energy at least 10 J below the maximal energy deliverable by the implanted device.
The CRT-D was implanted in 65 patients. The first defibrillation test was successful in 57 (88%) patients. In the remaining 8 patients (12%), the defibrillation test was unsuccessful. These patients required system revision: reprogramming shocking polarity (2), reversing polarity and adjusting waveform (3), lead repositioning (1) and adding a subcutaneous lead (2). The use of high output devices (maximal energy > 30 J) and dual-coil leads was associated with a significantly (p < 0.05) lower rate of high DER, although high DER occurred in one patient implanted with the high output device. There was a correlation between the probability of successful defibrillation and renal function. It was less likely to obtain successful defibrillation safety margin in patients with creatinine > 175 micromol/L. During the follow up, ventricular tachyarrhythmia detected in the VF detection zone occurred in 13 (20%) patients, including two patients, who required system modification during implantation. In both cases, VF was terminated by the first defibrillation with the maximal energy of the implanted devices.
High DER occurred in a significant number of CRT-D recipients. There is a correlation between high DER and impaired renal function. The use of high output devices significantly decreases the number of patients who required system modification in order to obtain an adequate defibrillation safety margin.
在植入心脏复律除颤器(ICD)期间,评估除颤能量需求(DER)是一项标准操作。建议确保植入设备可提供的最大能量至少降低 10 J 时,能成功转复诱发的心室颤动(VF)。由于反复诱发 VF,心脏再同步治疗除颤器(CRT-D)的接受者发生严重并发症的风险增加。
定义 CRT-D 接受者中 DER 较高的发生率,并确定获得除颤安全裕度的因素。
我们检查了 2006 年 6 月至 2009 年 6 月在我院植入 CRT-D 的所有患者。验证 DER 需要至少一次用能量降低植入设备可提供的最大能量至少 10 J 来终止诱发的 VF。
65 例患者植入 CRT-D。57 例(88%)患者首次除颤测试成功。在其余 8 例(12%)患者中,除颤测试不成功。这些患者需要系统修订:改变电击极性(2 例)、反转极性和调整波形(3 例)、重新定位导联(1 例)和增加皮下导联(2 例)。使用高输出设备(最大能量>30 J)和双极导联与 DER 较高的发生率显著相关(p<0.05),尽管一名植入高输出设备的患者发生了 DER 较高。成功除颤的概率与肾功能之间存在相关性。在肌酐>175 μmol/L 的患者中,获得成功除颤安全裕度的可能性较低。在随访期间,VF 检测区检测到的室性心动过速在 13 例(20%)患者中发生,其中 2 例患者在植入期间需要系统修改。在这两种情况下,VF 均通过植入设备的最大能量首次除颤终止。
在 CRT-D 接受者中,DER 较高的发生率显著。DER 与肾功能受损之间存在相关性。使用高输出设备可显著减少需要系统修改以获得足够除颤安全裕度的患者数量。